Clinical Trials Directory

Trials / Completed

CompletedNCT00227058

Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis

Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (planned)
Sponsor
University of Mississippi Medical Center · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to learn if two nutritional supplements, Orotic Acid and Glutathione will have any effect on the immune system response and if there will be any effect on the symptoms of seasonal allergies. It is our thinking that they will have an positive effect.

Detailed description

Current therapy for most immune-based diseases center around the use of anti inflammatory agents, many of which have unpleasant or dangerous side effects. Allergic rhinitis affects over 40 million Americans and its morbidity results from a combination of physical and psychological symptoms. The primary immunopathology has been defined as an imbalance of TH1/TH2 cytokines production resulting in increased allergen-specific IgE production, mast cell activation and eosinophil recruitment/activity. Metallic salts of orotic acid (OR), a natural intermediate in pyrimidine nucleic acid synthesis have been utilized to improve the signs and symptoms of a variety of maladies including the common cold, allergies and as preventatives for cancer and heart disease. Recent studies have reported that moderate doses of OR can mitigate or prevent endocrine and subjective psychological stresses in an acute laboratory stress model. All these findings lead us to hypothesize that OR salts administration will alleviate or eliminate the signs and symptoms associated with seasonal AR through a protective effect that involves direct anti-inflammatory immune effects and/or immunomodulation that include leukocyte trafficking, immunoregulatory cytokine balance and/or decrease inflammatory cell activity.

Conditions

Interventions

TypeNameDescription
DRUGOrotic acid and Glutathione-(Nutritional Supplements)

Timeline

Start date
2005-01-01
Completion
2005-11-01
First posted
2005-09-27
Last updated
2007-01-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00227058. Inclusion in this directory is not an endorsement.